An examination of male and female odds ratios by BMI, cigarette smoking, and alcohol consumption for cancers of the oral cavity, pharynx, and larynx in pooled data from 15 case-control studies

Imagem de Miniatura
Arquivos
art_LUBIN_An_examination_of_male_and_female_odds_ratios_2011.PDF (351.67 KB)
Citações na Scopus
47
Tipo de produção
article
Data de publicação
2011
DOI
Scopus
Web of Science
PubMed
Título da Revista
ISSN da Revista
Título do Volume
Editora
SPRINGER
Autores
LUBIN, Jay H.
MUSCAT, Joshua
GAUDET, Mia M.
OLSHAN, Andrew F.
CURADO, Maria Paula
MASO, Luigino Dal
WUENSCH-FILHO, Victor
STURGIS, Erich M.
SZESZENIA-DABROWSKA, Neonilia
CASTELLSAGUE, Xavier
Citação
CANCER CAUSES & CONTROL, v.22, n.9, p.1217-1231, 2011
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Greater tobacco smoking and alcohol consumption and lower body mass index (BMI) increase odds ratios (OR) for oral cavity, oropharyngeal, hypopharyngeal, and laryngeal cancers; however, there are no comprehensive sex-specific comparisons of ORs for these factors. We analyzed 2,441 oral cavity (925 women and 1,516 men), 2,297 oropharynx (564 women and 1,733 men), 508 hypopharynx (96 women and 412 men), and 1,740 larynx (237 women and 1,503 men) cases from the INHANCE consortium of 15 head and neck cancer case-control studies. Controls numbered from 7,604 to 13,829 subjects, depending on analysis. Analyses fitted linear-exponential excess ORs models. ORs were increased in underweight (< 18.5 BMI) relative to normal weight (18.5-24.9) and reduced in overweight and obese categories (a parts per thousand yen25 BMI) for all sites and were homogeneous by sex. ORs by smoking and drinking in women compared with men were significantly greater for oropharyngeal cancer (p < 0.01 for both factors), suggestive for hypopharyngeal cancer (p = 0.05 and p = 0.06, respectively), but homogeneous for oral cavity (p = 0.56 and p = 0.64) and laryngeal (p = 0.18 and p = 0.72) cancers. The extent that OR modifications of smoking and drinking by sex for oropharyngeal and, possibly, hypopharyngeal cancers represent true associations, or derive from unmeasured confounders or unobserved sex-related disease subtypes (e.g., human papillomavirus-positive oropharyngeal cancer) remains to be clarified.
Palavras-chave
Alcohol consumption, Cigarette smoking, Interactions, Odds ratio models
URI
https://observatorio.fm.usp.br/handle/OPI/23317
Referências
  1. AKIBA S, 1990, ENV HLTH PERSPECT, P8719
  2. Ritchie JM, 2003, INT J CANCER, V104, P336, DOI 10.1002/ijc.10960
  3. Altieri A, 2004, ORAL ONCOL, V40, P904, DOI 10.1016/j.oraloncology.2004.04.005
  4. Jung AC, 2010, INT J CANCER, V126, P1882, DOI 10.1002/ijc.24911
  5. Reimers N, 2007, INT J CANCER, V120, P1731, DOI 10.1002/ijc.22355
  6. Kreimer AR, 2006, INT J CANCER, V118, P2293, DOI 10.1002/ijc.21577
  7. Ang KK, 2010, NEW ENGL J MED, V363, P24, DOI 10.1056/NEJMoa0912217
  8. Markowitz LE, 2009, J INFECT DIS, V200, P1059, DOI 10.1086/604729
  9. Baris D, 2009, J NATL CANCER I, V101, P1553, DOI 10.1093/jnci/djp361
  10. Franceschi S, 2000, ORAL ONCOL, V36, P106, DOI 10.1016/S1368-8375(99)00070-6
  11. BLOT WJ, 1988, CANCER RES, V48, P3282
  12. Schwartz SR, 2001, OTOLARYNG HEAD NECK, V125, P1, DOI 10.1067/mhn.2001.116979
  13. Muscat JE, 1996, CANCER RES, V56, P5192
  14. Bain C, 2004, J NATL CANCER I, V96, P826, DOI 10.1093/jnci/djh143
  15. Gillison ML, 2008, J NATL CANCER I, V100, P407, DOI 10.1093/jnci/djn025
  16. Rajkumar T, 2003, EUR J CANCER PREV, V12, P135, DOI 10.1097/01.cej.0000062796.86004.7c
  17. Paz IB, 1997, CANCER-AM CANCER SOC, V79, P595, DOI 10.1002/(SICI)1097-0142(19970201)79:3<595::AID-CNCR24>3.0.CO;2-Y
  18. Nilsson S, 2001, J EPIDEMIOL COMMUN H, V55, P825, DOI 10.1136/jech.55.11.825
  19. Lynch SM, 2009, AM J EPIDEMIOL, V170, P403, DOI 10.1093/aje/kwp134
  20. Hayes RB, 1999, CANCER CAUSE CONTROL, V10, P27, DOI 10.1023/A:1008876115797
  21. Stone KM, 2002, J INFECT DIS, V186, P1396, DOI 10.1086/344354
  22. Lubin JH, 2010, AM J EPIDEMIOL, V171, P1250, DOI 10.1093/aje/kwq088
  23. Hashibe M, 2007, J NATL CANCER I, V99, P777, DOI 10.1093/jnci/djk179
  24. Freedman ND, 2007, AM J EPIDEMIOL, V165, P1424, DOI 10.1093/aje/kwm051
  25. Gillison ML, 2007, HEAD NECK-J SCI SPEC, V29, P779, DOI 10.1002/hed.20573
  26. KABAT GC, 1994, INT J EPIDEMIOL, V23, P1137, DOI 10.1093/ije/23.6.1137
  27. Herrero R, 2003, J NATL CANCER I, V95, P1772, DOI 10.1093/jnci/djg/107
  28. Gaudet MM, 2010, INT J EPIDEMIOL, V39, P1091, DOI 10.1093/ije/dyp380
  29. Ide R, 2008, ORAL DIS, V14, P314, DOI 10.1111/j.1601-0825.2007.01378.x
  30. Olshan AF, 2000, CANCER EPIDEM BIOMAR, V9, P185
  31. Tachezy R, 2005, ORAL DIS, V11, P181
  32. Ghosh A, 2009, J PATHOL, V217, P408, DOI 10.1002/path.2464
  33. Karagas MR, 2005, CANCER LETT, V219, P63, DOI 10.1016/j.canlet.2004.10.006
  34. Lubin JH, 2009, AM J EPIDEMIOL, V170, P937, DOI 10.1093/aje/kwp222
  35. Hobbs CGL, 2006, CLIN OTOLARYNGOL, V31, P259, DOI 10.1111/j.1749-4486.2006.01246.x
  36. AXELSON O, 1978, SCAND J WORK ENV HEA, V4, P98
  37. BAIN C, 2004, J NATL CANCER I, V96, P1796
  38. Castelao JE, 2001, J NATL CANCER I, V93, P538, DOI 10.1093/jnci/93.7.538
  39. DAvanzo B, 1996, NUTR CANCER, V26, P219
  40. DURRLEMAN S, 1989, STAT MED, V8, P551, DOI 10.1002/sim.4780080504
  41. Flegal KM, 2010, AM J EPIDEMIOL, V173, P1
  42. Franceschi S, 2001, ANN ONCOL, V12, P331, DOI 10.1023/A:1011191809335
  43. Freedman ND, 2007, BRIT J CANCER, V96, P1469, DOI 10.1038/sj.bjc.6603713
  44. FREEDMAN ND, 2007, CANCER
  45. GAIL MH, 1988, AM J IND MED, P13119
  46. Gallus S, 2003, CANCER EPIDEM BIOMAR, V12, P514
  47. Garavello W, 2006, ANN ONCOL, V17, P1459, DOI 10.1093/annonc/mdl166
  48. Hashibe M, 2000, INT J CANCER, V88, P129, DOI 10.1002/1097-0215(20001001)88:1<129::AID-IJC20>3.3.CO;2-L
  49. Hashibe M, 2002, CANCER CAUSE CONTROL, V13, P55, DOI 10.1023/A:1013991025848
  50. Henschke CI, 2004, LUNG CANCER-J IASLC, V43, P1, DOI 10.1016/j.lungcan.2003.08.024
  51. Jemal A, 2003, INT J CANCER, V105, P101, DOI 10.1002/ijc.11020
  52. MAYNE AT, 2006, CANC EPIDEMIOLOGY PR, P674
  53. Nieto A, 2003, BRIT J CANCER, V89, P1667, DOI 10.1038/sj.bjc.6601347
  54. Olshan AF, 2006, CANC EPIDEMIOLOGY PR, P627
  55. Perneger TV, 2001, J NATL CANCER I, V93, P1600, DOI 10.1093/jnci/93.21.1600
  56. Preston DL, 2006, EPICURE USERS GUIDE
  57. Puente D, 2006, CANCER CAUSE CONTROL, V17, P71, DOI 10.1007/s10552-005-0389-0
  58. Purdue MP, 2009, AM J EPIDEMIOL, V169, P132, DOI 10.1093/aje/kwn306
  59. Risch HA, 2002, J NATL CANCER I, V94, P308
  60. Silverman DT, 2006, CANC EPIDEMIOLOGY PR, P1101
  61. WACHOLDER S, 1991, CONTROL CLIN TRIALS, V12, P457, DOI 10.1016/0197-2456(91)90006-8
  62. Zang EA, 2002, J NATL CANCER I, V94, P308

Coleções
Artigos e Materiais de Revistas Científicas - FM/MPR
Artigos e Materiais de Revistas Científicas - LIM/38